Is the deficiency of the long isoform of cellular FLICE-inhibitory protein involved in myocardial remodeling?

Hypertension

Volumn 56, Issue 6, 2010, Pages 1045-1046

  Díez, Javier ^a,b   González, Arantxa ^a   Ravassa, Susana ^a  

^a Centre of Applied Medical Research   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLICE INHIBITORY PROTEIN; ISOPROTEIN;

APOPTOSIS; DNA FRAGMENTATION; ENZYME ACTIVATION; HEART MUSCLE; HEART VENTRICLE REMODELING; MYOFIBROBLAST; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANGIOTENSIN II; ANIMALS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 10; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MICE; MICE, KNOCKOUT; MYOCYTES, CARDIAC; PROTEIN ISOFORMS; VENTRICULAR REMODELING;

EID: 78650414898     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.158485     Document Type: Note

References (10)

1. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262.
2. Li H, Tang Q-Z, Liu C, Moon M, Chen M, Yan L, Bian Z-Y, Zhang Y, Wang A-B, Nghiem MP, Yeh W-C, Liu PP. Cellular FLICE-inhibitory protein protects against cardiac remodeling induced by angiotensin II in mice. Hypertension. 2010;56:1109-1117.
3. Bagnoli M, Canevari S, Mezzanzanica D. Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apopto-sis in physiologic context and in cancer. Int J Biochem Cell Biol. 2010; 42:2010-2013.
4. Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N, Bonnard M, Goeddel DV, Mak TW. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embrionyc development. Immunity. 2000;12:633-642.
5. Giampietri C, Petrungaro S, Musumeci M, Coluccia P, Antonangeli F, De Cesaris P, Filippini A, Marano G, Ziparo E. c-Flip overexpression reduces cardiac hypertrophy in response to pressure overload. J Hypertens. 2008;26:1008-1016.
6. Yu JW, Jeffrey PD, Shi Y. Mechanisms of procaspase-8 activation by c-FLIPL. Proc Natl Acad Sci USA. 2009;106:8169-8174.
7. Leask A. Potential therapeutic targets for cardiac fibrosis: TGF/3, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res. 2010;106:1675-1680.
8. Imanishi T, Murry CE, Reinecke H, Hano T, Nishio I, Liles WC, Hofstra L, Kim K, O'Brien KD, Schwartz SM, Han DK. Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues. Cardiovasc Res. 2000;48:101-110.
9. Steenbergen C, Afshari CA, Petranka JG, Collins J, Martin K, Bennett L, Haugen A, Bsuhel P, Murphy E. Alterations in apoptotic signaling in human idiopathic cardiomyopathic hearts in failure. Am J Physiol Heart Circ Physiol. 2003;284:H268-H276.
10. Zolk O, Schenke C, Sarikas A. The ubiquitin-proteasome system: focus on the heart. Cardiovasc Res. 2006;70:410-421.